Abstract:e15772 Background: The minimum number of examined lymph nodes (ELNs) for accurate nodal staging remains controversial and has not been recommended by the NCCN guidelines for pancreatic adenocarcinoma (PADC). We aimed to evaluate the time trends in the ELN count and the proportion of node-positive PADC (N+%), as well as determine the minimal threshold for the ELN count. Methods: We analyzed 9258 patients with resectable PADC between 2000 and 2012 in the SEER database (18 registries). Changes in the ELN count and N+% over time were evaluated using the Spearman correlation analysis and the Cochran-Armitage test, respectively. Multivariable logistic and Cox models were used to evaluate the association between the ELN count and N+% and overall survival after adjusted for clinicopathologic features (i.e., race/ethnicity, sex, age, marital status, SEER region, year of diagnosis, tumor grade, tumor site, 8th AJCC T stage, and surgical type). Restricted cubic spline modeling was used to handle possible nonlinear effects of the ELN count as a continuous covariate in the multivariable models. Structural breakpoints, which were considered the threshold of clinical impact, were determined by the Chow test. Results: The median ELN count increased from 9 (interquartile range: 5−15) in 2000 to 16 (11−23) in 2012 ( Ptrend < 0.001), and the N+% increased from 61.1% to 67.2% ( Ptrend < 0.001). An increased ELN count was associated with a nonlinear increase in N+% ( P < 0.001), and the Chow test revealed a threshold ELN count of 8 (ORadjusted for ≥ 8 vs. < 8 ELNs, 2.42 [95% CI, 2.19−2.68]). The 8-ELN threshold was confirmed in patients with declared N0 disease: A larger number of ELNs was correlated with a nonlinear increase in overall survival among these patients ( P < 0.001), with the threshold ELN count also being 8 (HRadjustedfor ≥ 8 vs. < 8 ELNs, 0.79 [95% CI, 0.75−0.87]). Moreover, the 8-ELN threshold remained valid regardless of T stage and year of diagnosis. Conclusions: Lymph node examination has increased markedly over time and was associated with an overall shift toward higher-staged PADC. We recommend 8 ELNs as the cut point for improvement of prognostic accuracy and quality measurement of lymph node examination.

Role of Lymph Node Resection and Histopathological Evaluation in Accurate Staging of Nonfunctional Pancreatic Neuroendocrine Tumors: How Many Are Enough?

The Relationship Between the Number of Examined Lymph Nodes and the Efficacy of Chemotherapy for Gastric Cancer

Number of Positive Lymph Nodes is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms

Prognostic Value of Lymph Node Positivity and Number of Lymph Nodes Required for Accurate Staging of Pancreatic Neuroendocrine Tumors.

The Lymph node ratio optimizes staging in patients with small intestinal neuroendocrine tumors.

Determining the Optimal Number of Examined Lymph Nodes for Accurate Staging of Pancreatic Cancer: an Analysis Using the Nodal Staging Score Model.

Significance of Examined Lymph Node Number in Accurate Staging and Long-Term Survival in Resected Stage I-II Pancreatic Cancer: More is Better? A Large International Population-Based Cohort Study.

Proposal Of The Optimal Numbers Of Examined And Positive Lymph Nodes To The 8th Edition Of American Joint Committee On Cancer (Ajcc) Staging For 758 Patients With Distal Cholangiocarcinoma

Impact of examined lymph node count on prognosis in patients with lymph node-negative pancreatic body/tail ductal adenocarcinoma.

A Novel Criterion for Lymph Nodes Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database

Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study

Association Between Lymph Node Examination and Nodal Staging for Pancreatic Adenocarcinoma: A Population-Based Analysis.

Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the Us Seer Database and A Chinese Multi-Institutional Registry

Preoperative Neutrophil-to-lymphocyte Ratio and Tumor-Related Factors to Predict Lymph Node Metastasis in Nonfunctioning Pancreatic Neuroendocrine Tumors.

Prognostic Importance of Numbers of Retrieved Lymph Nodes and Positive Lymph Nodes for Ampulla of Vater Cancer (AVC) in 2347 Patients from the Surveillance, Epidemiology, and End Results (SEER) Database.

Preoperative Prediction of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors Using a Combined CT Radiomics-Clinical Model

Assessing the Adequacy of Lymph Node Yield for Different Tumor Stages of Colon Cancer by Nodal Staging Scores.

Lymph Node Counts and Ratio in Axillary Dissections Following Neoadjuvant Chemotherapy for Breast Cancer: A Better Alternative to Traditional Pn Staging

Defining the Minimal and Optimal Thresholds for Lymph Node Resection and Examination for Intraductal Papillary Mucinous Neoplasm Derived Pancreatic Cancer

When Should Lymphadenectomy Be Performed in Non-Metastatic Pancreatic Neuroendocrine Tumors? A Population-Based Analysis of the German Clinical Cancer Registry Group

Effect of the Number of Positive Lymph Nodes and Lymph Node Ratio on Prognosis of Patients after Resection of Pancreatic Adenocarcinoma